A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Chr. Hansen

Company-logo  COMPANY DETAILS
Chr. Hansen
10-12 Bøge Allé
Hørsholm
DK-2970
Denmark

Website
Mail
Call
  +45 45 74 74 74


Printer
  +45 45 74 88 88

HEALTH CATEGORIES

digestive health


Facebook   
Google   
Linkedin   
Twitter   
Youtube   

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.



Articles On NutritionInsight
FormattedPicture

NUTRITION & HEALTH NEWS

Lonza 2019 results: Nutritional hard capsule business dips amid strong sales in Pharma Biotech & Nutrition

21 Jan 2020 --- Increased competition in the space of nutritional hard capsules has negatively impacted Lonza Group’s fiscal 2019 profits, although the company reports overall strong sales... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Weekly Roundup: Catalent acquires Bristol-Myers Squibb’s production site, KD Pharma refinances US$166m debt facilities

10 Jan 2020 --- In nutrition news this week, Catalent completed the purchase of Biologics Fill-Finish and Oral Solid Dose Facility, while KD Pharma rearranged and expanded its debt facilities,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Few hospitals can cater to the proper nutrition of premature babies, study finds

10 Dec 2019 --- The majority of neonatal intensive care units (NICUs) participating in the Children’s Hospitals Neonatal Consortium are unable to reliably and consistently monitor caloric... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

“The tip of the iceberg”: DuPont scientist reveals role of subconscious processing in product reformulation

09 Dec 2019 --- Brain scans are a key tool in enabling reformulators to create a product that consumers respond positively to at all levels of consciousness. This is according to Camilla Arndal... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Supporting intestinal health: Chr. Hansen’s three-strain probiotic blend for preterm babies

29 Nov 2019 --- A new three-strain probiotic blend from Chr. Hansen may help support intestinal health and development in preterm babies. It has been shown to reduce the risk of Necrotizing... Read More




Video Interviews
FormattedPicture

Probiotic Oil Drops for Infants and Young Children

Chr. Hansen has launched a new probiotic product which has the potential to improve the gut and immune health of infants and young children: probiotic drops containing Chr. Hansen’s bacteria strain BB-12 and sunflower oil.

FormattedPicture

Taking Probiotics to Juice Applications

Marie Brenoe of Chr. Hansen on Taking Probiotics to Juice Applications.




Articles On The World of Food Ingredients
FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Chr. Hansen Partners on Tomorrow’s Cultures

01 Feb 2016 --- Danish-headquartered Chr. Hansen has reported a strong start to the 2015/2016 financial year. An interview with Sten Estrup, VP at Chr. Hansen who talks about how new partnerships are indicative of how the company is investing in the future.

FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Opinion Edge: How to Ride the Next Dairy Trend

30 Nov 2014 --- Key suppliers offer their thoughts on the key dairy trends. How can manufacturers benefit from the mainstreaming of the sports nutrition sector? How can the boom in protein and the needs of the aging global population be addressed?

FormattedPicture

THE WORLD OF FOOD INGREDIENTS

View from the Top: Knud Vindfeldt, Head of Cultures & Enzymes, Chr. Hansen

01 Mar 2013 --- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”




Podcasts
FormattedPicture

New opportunities for good bacteria

Mauricio Graber took the helm as new Chr. Hansen CEO on June 1, 2018, having previously served as President of the Flavours Division of Givaudan. Chr. Hansen recently reported its Q4 and full financial earnings. The company announced that it had achieved the overall financial targets set at the beginning of the year and raised its ambitions 9-11 percent organic growth for next year. It is the company’s core business of Cultures & Enzymes, which represents 59 percent of their business that performed the strongest, with bioprotection and probiotics forming key pillars here. FoodIngredientsFirst spoke with Mauricio about the current business environment and new opportunities for microbes.

FormattedPicture

Chr. Hansen targets organic growth through innovation

Danish-headquartered ingredients supplier Chr. Hansen recently announced its annual results, with organic growth reported of 10 percent for 2016/2017. Food Cultures & Enzymes and Health & Nutrition both delivered strong growth, performing slightly above the long-term ambitions for these businesses, while Natural Colors grew in line with ambitions. The key focus for Chr. Hansen continues to be strong organic growth through innovation and the company notes that with good progress in many of its strategic initiatives, the building blocks for achieving its ambitious financial targets are in place.Soeren Westh Lonning, CFO at Chr. Hansen discusses the company’s strategy shortly after the results were announced. 




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W